(191538, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191539, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191540, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191541, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191542, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191543, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191544, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191545, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191546, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191547, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191548, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191549, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191550, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191551, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191552, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191553, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191554, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191555, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191556, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191557, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191558, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191559, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191560, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191561, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191562, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191563, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191564, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191565, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191566, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191567, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191568, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191569, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191570, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191571, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191572, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191573, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191574, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191575, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191576, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191577, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191578, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191579, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191580, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191581, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191582, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191583, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191584, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191585, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191586, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191587, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191588, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191589, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191590, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191591, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191592, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191593, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191594, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191595, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191596, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191597, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191598, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191599, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191600, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191601, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191602, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191603, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191604, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191605, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191606, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191607, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191608, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191609, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191610, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191611, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191612, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191613, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191614, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191615, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191616, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191617, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191618, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191619, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191620, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191621, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191622, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191623, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191624, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191625, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191626, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191627, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191628, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191629, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191630, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191631, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191632, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191633, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191634, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191635, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191636, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191637, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191638, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191639, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191640, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191641, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191642, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191643, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191644, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191645, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191646, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191647, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191648, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191649, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191650, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191651, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191652, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191653, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191654, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191655, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191656, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191657, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191658, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191659, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191660, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191661, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191662, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191663, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191664, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191665, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191666, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191667, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191668, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191669, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191670, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191671, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191672, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191673, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191674, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191675, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191676, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191677, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191678, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191679, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191680, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191681, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191682, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191683, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191684, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191685, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191686, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191687, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191688, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191689, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191690, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191691, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191692, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191693, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191694, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191695, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191696, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191697, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191698, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191699, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191700, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191701, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191702, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191703, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191704, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191705, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191706, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191707, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191708, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191709, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191710, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191711, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191712, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191713, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191714, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191715, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191716, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191717, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191718, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191719, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191720, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191721, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191722, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191723, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191724, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191725, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191726, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191727, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191728, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191729, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191730, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191731, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191732, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191733, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191734, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191735, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191736, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191737, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191738, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191739, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191740, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191741, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191742, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191743, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191744, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191745, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191746, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191747, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191748, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191749, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191750, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191751, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191752, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191753, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191754, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191755, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191756, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191757, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191758, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191759, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191760, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191761, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191762, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191763, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191764, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191765, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191766, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191767, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191768, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191769, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191770, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191771, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191772, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191773, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191774, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191775, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191776, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191777, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191778, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191779, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191780, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191781, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191782, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191783, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191784, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191785, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191786, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191787, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191788, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191789, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191790, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191791, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191792, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191793, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191794, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191795, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191796, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191797, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191798, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191799, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191800, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191801, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191802, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191803, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191804, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191805, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191806, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191807, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191808, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191809, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191810, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191811, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191812, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191813, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191814, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191815, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191816, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191817, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191818, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191819, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191820, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191821, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191822, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191823, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191824, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191825, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191826, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191827, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191828, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191829, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191830, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191831, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191832, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191833, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191834, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191835, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191836, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191837, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191838, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191839, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191840, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191841, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191842, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191843, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191844, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191845, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191846, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191847, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191848, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191849, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191850, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191851, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191852, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191853, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191854, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191855, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191856, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191857, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191858, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191859, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191860, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191861, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191862, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191863, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191864, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191865, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191866, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191867, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191868, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191869, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191870, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191871, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191872, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191873, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191874, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191875, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191876, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191877, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191878, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191879, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191880, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191881, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191882, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191883, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191884, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191885, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191886, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191887, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191888, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191889, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191890, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191891, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191892, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191893, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191894, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191895, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191896, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191897, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191898, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191899, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191900, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191901, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191902, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191903, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191904, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191905, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191906, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191907, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191908, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191909, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191910, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191911, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191912, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191913, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191914, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191915, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191916, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191917, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191918, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191919, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191920, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191921, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191922, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191923, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191924, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191925, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191926, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191927, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191928, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191929, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191930, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191931, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191932, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191933, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191934, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191935, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191936, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191937, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191938, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191939, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191940, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191941, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191942, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191943, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191944, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191945, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191946, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191947, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191948, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191949, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191950, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191951, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191952, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191953, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191954, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191955, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191956, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191957, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191958, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191959, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191960, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191961, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191962, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191963, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191964, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191965, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191966, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191967, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191968, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191969, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191970, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191971, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191972, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191973, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191974, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191975, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191976, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191977, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191978, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191979, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191980, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191981, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191982, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191983, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191984, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191985, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191986, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191987, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191988, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191989, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191990, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191991, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191992, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191993, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191994, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191995, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191996, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191997, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191998, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191999, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192000, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192001, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192002, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192003, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192004, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192005, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192006, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192007, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192008, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192009, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192010, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192011, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192012, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192013, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192014, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192015, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192016, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192017, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192018, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(192019, 'HP:5200006', 'Loose association', 'MP:0003464', 'abnormal single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192020, 'HP:5200006', 'Loose association', 'MP:0021015', 'increased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192021, 'HP:5200006', 'Loose association', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192022, 'HP:5200006', 'Loose association', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192023, 'HP:5200006', 'Loose association', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192024, 'HP:5200006', 'Loose association', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192025, 'HP:5200006', 'Loose association', 'MP:0004994', 'abnormal brain wave pattern', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192026, 'HP:5200006', 'Loose association', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192027, 'HP:5200006', 'Loose association', 'MP:0002635', 'reduced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192028, 'HP:5200006', 'Loose association', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192029, 'HP:5200006', 'Loose association', 'MP:0003477', 'abnormal nerve fiber response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192030, 'HP:5200006', 'Loose association', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192031, 'HP:5200006', 'Loose association', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192032, 'HP:5200006', 'Loose association', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192033, 'HP:5200006', 'Loose association', 'MP:0002578', 'impaired ability to fire action potentials', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192034, 'HP:5200006', 'Loose association', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192035, 'HP:5200006', 'Loose association', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192036, 'HP:5200006', 'Loose association', 'MP:0003474', 'abnormal summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192037, 'HP:5200006', 'Loose association', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192038, 'HP:5200006', 'Loose association', 'MP:0003889', 'enhanced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192039, 'HP:5200006', 'Loose association', 'MP:0003467', 'abnormal single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192040, 'HP:5200006', 'Loose association', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192041, 'HP:5200006', 'Loose association', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192042, 'HP:5200006', 'Loose association', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192043, 'HP:5200006', 'Loose association', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192044, 'HP:5200006', 'Loose association', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192045, 'HP:5200006', 'Loose association', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192046, 'HP:5200006', 'Loose association', 'MP:0006080', 'brain ischemia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192047, 'HP:5200006', 'Loose association', 'MP:0005402', 'abnormal action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192048, 'HP:5200006', 'Loose association', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192049, 'HP:5200006', 'Loose association', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192050, 'HP:5200006', 'Loose association', 'MP:0002634', 'abnormal sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192051, 'HP:5200006', 'Loose association', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192052, 'HP:5200006', 'Loose association', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192053, 'HP:5200006', 'Loose association', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192054, 'HP:5200006', 'Loose association', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192055, 'HP:5200006', 'Loose association', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192056, 'HP:5200006', 'Loose association', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192057, 'HP:5200006', 'Loose association', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192058, 'HP:5200006', 'Loose association', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192059, 'HP:5200006', 'Loose association', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192060, 'HP:5200006', 'Loose association', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192061, 'HP:5200006', 'Loose association', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192062, 'HP:5200006', 'Loose association', 'MP:0008814', 'decreased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192063, 'HP:5200006', 'Loose association', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(192064, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0001560', 'abnormal circulating insulin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192065, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012615', 'decreased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192066, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0013403', 'abnormal circulating lactate level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(192067, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0008806', 'increased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192068, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0005308', 'abnormal circulating ammonia level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192069, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192070, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011894', 'decreased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192071, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031107', 'abnormal circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192072, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192073, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012622', 'increased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192074, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0001570', 'abnormal circulating enzyme level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192075, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192076, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192077, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192078, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011888', 'abnormal circulating total protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192079, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011912', 'abnormal circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192080, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031077', 'increased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192081, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192082, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020256', 'abnormal circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192083, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192084, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031079', 'increased circulating troponin I level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192085, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192086, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192087, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031083', 'increased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192088, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192089, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010090', 'increased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192090, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192091, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011889', 'abnormal circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192092, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0008820', 'abnormal blood uric acid level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192093, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192094, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192095, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192096, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012325', 'decreased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192097, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0013256', 'increased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192098, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192099, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192100, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012621', 'decreased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192101, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012666', 'increased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192102, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012328', 'decreased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192103, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0003349', 'abnormal circulating renin level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192104, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0005667', 'abnormal circulating leptin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192105, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192106, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012614', 'abnormal circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192107, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031075', 'abnormal circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192108, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012616', 'increased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192109, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011885', 'abnormal circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192110, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192111, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192112, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031076', 'decreased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192113, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0013257', 'decreased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192114, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0013255', 'abnormal circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192115, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0005419', 'decreased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192116, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0008804', 'abnormal circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192117, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031082', 'decreased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192118, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012331', 'increased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192119, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192120, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012332', 'decreased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192121, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011890', 'increased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192122, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020985', 'increased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192123, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192124, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020247', 'increased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192125, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192126, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192127, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020983', 'abnormal circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192128, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192129, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192130, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192131, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192132, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192133, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020246', 'abnormal circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192134, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012619', 'increased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192135, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012221', 'abnormal circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192136, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192137, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192138, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192139, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192140, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0002965', 'increased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192141, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192142, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192143, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192144, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011892', 'abnormal circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192145, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011893', 'increased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192146, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031065', 'increased circulating procalcitonin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192147, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192148, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192149, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031108', 'increased circulating myoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192150, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0005416', 'abnormal circulating protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192151, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012222', 'decreased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192152, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020258', 'decreased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192153, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0004730', 'abnormal circulating gastrin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192154, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192155, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192156, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192157, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192158, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192159, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010210', 'abnormal circulating cytokine level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192160, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192161, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192162, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0002941', 'increased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192163, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012333', 'increased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192164, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012617', 'abnormal circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192165, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012618', 'decreased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192166, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192167, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192168, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011891', 'decreased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192169, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011887', 'decreased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192170, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012326', 'increased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192171, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031078', 'increased circulating troponin T level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192172, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192173, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192174, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192175, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192176, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192177, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192178, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192179, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020257', 'increased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192180, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012330', 'decreased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192181, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031081', 'abnormal circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192182, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192183, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0030757', 'abnormal circulating histamine level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192184, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192185, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010091', 'decreased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192186, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012223', 'increased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192187, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0002695', 'abnormal circulating glucagon level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192188, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020255', 'absent circulating factor XII protein', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192189, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0005567', 'decreased circulating total protein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192190, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192191, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012327', 'abnormal circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192192, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031059', 'increased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192193, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012324', 'abnormal circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192194, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0010215', 'abnormal circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192195, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0008805', 'decreased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192196, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020984', 'decreased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192197, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011886', 'increased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192198, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192199, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192200, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0012329', 'increased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192201, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192202, 'HP:0031425', 'Increased circulating beta-C-terminal telopeptide concentration', 'MP:0020248', 'decreased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192203, 'HP:0025604', 'Orbital schwannoma', 'MP:0030063', 'abnormal face size', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(192204, 'HP:0025604', 'Orbital schwannoma', 'MP:0031498', 'abnormal cornea size', 0.41509433962264153, 6.679863125803252, 1.6651646684261996, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192205, 'HP:0025604', 'Orbital schwannoma', 'MP:0002092', 'abnormal eye morphology', 0.4186046511627907, 6.679863125803252, 1.6721907108915715, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192206, 'HP:0025604', 'Orbital schwannoma', 'MP:0001297', 'microphthalmia', 0.44, 8.581084971325078, 1.9431102355201144, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192207, 'HP:0025604', 'Orbital schwannoma', 'MP:0006200', 'vitreous body deposition', 0.40816326530612246, 6.679863125803252, 1.651204028951546, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192208, 'HP:0025604', 'Orbital schwannoma', 'MP:0003102', 'sclera thinning', 0.4230769230769231, 6.679863125803252, 1.6810996216286045, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192209, 'HP:0025604', 'Orbital schwannoma', 'MP:0002697', 'abnormal eye size', 0.4782608695652174, 8.581084971325078, 2.025832461038906, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192210, 'HP:0025604', 'Orbital schwannoma', 'MP:0031290', 'bilateral microphthalmia', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192211, 'HP:0025604', 'Orbital schwannoma', 'MP:0014176', 'abnormal cilary zonule morphology', 0.41304347826086957, 6.679863125803252, 1.6610460257886595, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192212, 'HP:0025604', 'Orbital schwannoma', 'MP:0030041', 'abnormal forehead size', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(192213, 'HP:0025604', 'Orbital schwannoma', 'MP:0003381', 'vitreal fibroplasia', 0.40816326530612246, 6.679863125803252, 1.651204028951546, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192214, 'HP:0025604', 'Orbital schwannoma', 'MP:0013146', 'eye lesions', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192215, 'HP:0025604', 'Orbital schwannoma', 'MP:0005299', 'abnormal eye posterior chamber morphology', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192216, 'HP:0025604', 'Orbital schwannoma', 'MP:0012351', 'cornea degeneration', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192217, 'HP:0025604', 'Orbital schwannoma', 'MP:0003671', 'abnormal eyelid aperture', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192218, 'HP:0025604', 'Orbital schwannoma', 'MP:0010081', 'posterior microphthalmia', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192219, 'HP:0025604', 'Orbital schwannoma', 'MP:0001299', 'abnormal eye distance/ position', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192220, 'HP:0025604', 'Orbital schwannoma', 'MP:0009274', 'buphthalmos', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192221, 'HP:0025604', 'Orbital schwannoma', 'MP:0006166', 'eyelid retraction', 0.42, 6.679863125803252, 1.674975376785392, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192222, 'HP:0025604', 'Orbital schwannoma', 'MP:0014087', 'retrolental blood', 0.41304347826086957, 6.679863125803252, 1.6610460257886595, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192223, 'HP:0025604', 'Orbital schwannoma', 'MP:0001306', 'small lens', 0.4230769230769231, 6.679863125803252, 1.6810996216286045, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192224, 'HP:0025604', 'Orbital schwannoma', 'MP:0013396', 'eyelid hyperplasia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192225, 'HP:0025604', 'Orbital schwannoma', 'MP:0008841', 'ruptured lens capsule', 0.4230769230769231, 6.679863125803252, 1.6810996216286045, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192226, 'HP:0025604', 'Orbital schwannoma', 'MP:0031289', 'unilateral microphthalmia', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192227, 'HP:0025604', 'Orbital schwannoma', 'MP:0001303', 'abnormal lens morphology', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192228, 'HP:0025604', 'Orbital schwannoma', 'MP:0006249', 'phthisis bulbi', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192229, 'HP:0025604', 'Orbital schwannoma', 'MP:0031432', 'cornea perforation', 0.41509433962264153, 6.679863125803252, 1.6651646684261996, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192230, 'HP:0025604', 'Orbital schwannoma', 'MP:0005176', 'eyelids fail to open', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192231, 'HP:0025604', 'Orbital schwannoma', 'MP:0005193', 'abnormal anterior eye segment morphology', 0.4222222222222222, 6.679863125803252, 1.6794006827189658, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192232, 'HP:0025604', 'Orbital schwannoma', 'MP:0008815', 'anterior staphyloma', 0.41304347826086957, 6.679863125803252, 1.6610460257886595, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192233, 'HP:0025604', 'Orbital schwannoma', 'MP:0002699', 'abnormal vitreous body morphology', 0.4166666666666667, 6.679863125803252, 1.6683154085537968, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192234, 'HP:0025604', 'Orbital schwannoma', 'MP:0006225', 'ocular rupture', 0.4782608695652174, 8.581084971325078, 2.025832461038906, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192235, 'HP:0025604', 'Orbital schwannoma', 'MP:0001305', 'enlarged lens', 0.4230769230769231, 6.679863125803252, 1.6810996216286045, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192236, 'HP:0025604', 'Orbital schwannoma', 'MP:0006209', 'calcified intraocular region', 0.4782608695652174, 8.581084971325078, 2.025832461038906, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192237, 'HP:0025604', 'Orbital schwannoma', 'MP:0002698', 'abnormal sclera morphology', 0.4222222222222222, 6.679863125803252, 1.6794006827189658, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192238, 'HP:0025604', 'Orbital schwannoma', 'MP:0001286', 'abnormal eye development', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192239, 'HP:0025604', 'Orbital schwannoma', 'MP:0001296', 'macrophthalmia', 0.44, 8.581084971325078, 1.9431102355201144, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192240, 'HP:0025604', 'Orbital schwannoma', 'MP:0031317', 'spherophakia', 0.41509433962264153, 6.679863125803252, 1.6651646684261996, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192241, 'HP:0025604', 'Orbital schwannoma', 'MP:0009859', 'eye opacity', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192242, 'HP:0025604', 'Orbital schwannoma', 'MP:0006248', 'lagophthalmos', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(192243, 'HP:0025604', 'Orbital schwannoma', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.4222222222222222, 6.679863125803252, 1.6794006827189658, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192244, 'HP:0025604', 'Orbital schwannoma', 'MP:0009829', 'enlarged eye anterior chamber', 0.41509433962264153, 6.679863125803252, 1.6651646684261996, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192245, 'HP:0025604', 'Orbital schwannoma', 'MP:0006164', 'ectropion', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192246, 'HP:0025604', 'Orbital schwannoma', 'MP:0005197', 'abnormal uvea morphology', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192247, 'HP:0025604', 'Orbital schwannoma', 'MP:0002864', 'abnormal ocular fundus morphology', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192248, 'HP:0025604', 'Orbital schwannoma', 'MP:0005205', 'abnormal eye anterior chamber morphology', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(192249, 'HP:0002297', 'Red hair', 'MP:0000420', 'ruffled hair', 0.4074074074074074, 9.944182255188846, 2.012792466046421, 'UPHENO:0075677', 'abnormal strand of hair'),
(192250, 'HP:0002297', 'Red hair', 'MP:0009457', 'whorled hair', 0.40425531914893614, 9.944182255188846, 2.004990915502251, 'UPHENO:0075677', 'abnormal strand of hair'),
(192251, 'HP:0002297', 'Red hair', 'MP:0013111', 'greasy abdomen coat', 0.43137254901960786, 9.944182255188846, 2.071146360674775, 'UPHENO:0075677', 'abnormal strand of hair'),
(192252, 'HP:0002297', 'Red hair', 'MP:0010142', 'disorganized hair shaft', 0.4489795918367347, 9.944182255188846, 2.1129919285422716, 'UPHENO:0075677', 'abnormal strand of hair'),
(192253, 'HP:0002297', 'Red hair', 'MP:0002074', 'abnormal hair texture', 0.40425531914893614, 9.944182255188846, 2.004990915502251, 'UPHENO:0075677', 'abnormal strand of hair'),
(192254, 'HP:0002297', 'Red hair', 'MP:0009270', 'abnormal guard hair length', 0.4230769230769231, 9.944182255188846, 2.0511348154232656, 'UPHENO:0075677', 'abnormal strand of hair'),
(192255, 'HP:0002297', 'Red hair', 'MP:0013112', 'greasy thorax coat', 0.43137254901960786, 9.944182255188846, 2.071146360674775, 'UPHENO:0075677', 'abnormal strand of hair'),
(192256, 'HP:0002297', 'Red hair', 'MP:0003136', 'yellow coat color', 0.4807692307692308, 15.192109768632433, 2.7025726497593237, 'UPHENO:0083439', 'abnormally color strand of hair color'),
(192257, 'HP:0002297', 'Red hair', 'MP:0003809', 'abnormal hair shaft morphology', 0.41304347826086957, 9.944182255188846, 2.0266671229245365, 'UPHENO:0075677', 'abnormal strand of hair'),
(192258, 'HP:0002297', 'Red hair', 'MP:0000410', 'waved hair', 0.4074074074074074, 9.944182255188846, 2.012792466046421, 'UPHENO:0075677', 'abnormal strand of hair'),
(192259, 'HP:0002297', 'Red hair', 'MP:0009351', 'thin hair shaft', 0.41509433962264153, 9.944182255188846, 2.031692340465161, 'UPHENO:0075677', 'abnormal strand of hair'),
(192260, 'HP:0002297', 'Red hair', 'MP:0003849', 'greasy coat', 0.44, 9.944182255188846, 2.0917552897705534, 'UPHENO:0075677', 'abnormal strand of hair'),
(192261, 'HP:0002297', 'Red hair', 'MP:0030921', 'abnormal hair club morphology', 0.40425531914893614, 9.944182255188846, 2.004990915502251, 'UPHENO:0075677', 'abnormal strand of hair'),
(192262, 'HP:0002297', 'Red hair', 'MP:0001190', 'reddish skin', 0.4318181818181818, 14.192109768632433, 2.475562771665246, 'UPHENO:0083451', 'abnormally red anatomical entity color'),
(192263, 'HP:0500048', 'Delayed canalization of nasolacrimal duct', 'MP:0008969', 'abnormal nasolacrimal duct morphology', 0.4074074074074074, 12.607147267911277, 2.2663285691230017, 'UPHENO:0076731', 'abnormal lacrimal drainage system morphology'),
(192264, 'HP:0500048', 'Delayed canalization of nasolacrimal duct', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.40384615384615385, 11.799792345853673, 2.1829568834624955, 'UPHENO:0088074', 'abnormal lacrimal apparatus morphology'),
(192265, 'HP:0500048', 'Delayed canalization of nasolacrimal duct', 'MP:0013451', 'nasolacrimal duct obstruction', 0.48214285714285715, 12.607147267911277, 2.4654504667852297, 'UPHENO:0076731', 'abnormal lacrimal drainage system morphology'),
(192266, 'HP:0003108', 'Hyperglycinuria', 'MP:0003311', 'aminoaciduria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192267, 'HP:0003108', 'Hyperglycinuria', 'MP:0020404', 'prolinuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192268, 'HP:0003108', 'Hyperglycinuria', 'MP:0030682', 'hydroxyprolinuria', 0.449438202247191, 11.226325483970346, 2.246227847605282, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192269, 'HP:0003108', 'Hyperglycinuria', 'MP:0020405', 'taurinuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192270, 'HP:0003108', 'Hyperglycinuria', 'MP:0020402', 'ornithinuria', 0.47126436781609193, 11.226325483970346, 2.3001232971519086, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192271, 'HP:0003108', 'Hyperglycinuria', 'MP:0030613', 'dicarboxylic aciduria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(192272, 'HP:0003108', 'Hyperglycinuria', 'MP:0020400', 'cystinuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192273, 'HP:0003108', 'Hyperglycinuria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.47126436781609193, 11.226325483970346, 2.3001232971519086, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192274, 'HP:0003108', 'Hyperglycinuria', 'MP:0030618', 'tryptophanuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192275, 'HP:0003108', 'Hyperglycinuria', 'MP:0011516', 'aspartylglucosaminuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192276, 'HP:0003108', 'Hyperglycinuria', 'MP:0030617', 'hyperglutaminuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192277, 'HP:0003108', 'Hyperglycinuria', 'MP:0011765', 'oroticaciduria', 0.44871794871794873, 10.47786425096631, 2.168318646702723, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(192278, 'HP:0003108', 'Hyperglycinuria', 'MP:0020403', 'lysinuria', 0.4659090909090909, 11.226325483970346, 2.287017074812994, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192279, 'HP:0003108', 'Hyperglycinuria', 'MP:0020401', 'argininuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192280, 'HP:0003108', 'Hyperglycinuria', 'MP:0011470', 'increased urine creatinine level', 0.4074074074074074, 11.094077685671904, 2.125984343191633, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(192281, 'HP:0003108', 'Hyperglycinuria', 'MP:0011654', 'histidinuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192282, 'HP:0003108', 'Hyperglycinuria', 'MP:0030620', 'valinuria', 0.4659090909090909, 11.226325483970346, 2.287017074812994, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192283, 'HP:0003108', 'Hyperglycinuria', 'MP:0013730', 'glutathionuria', 0.4606741573033708, 11.226325483970346, 2.2741323690456974, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192284, 'HP:0003108', 'Hyperglycinuria', 'MP:0020406', 'hyperthreoninuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192285, 'HP:0003108', 'Hyperglycinuria', 'MP:0030689', 'cystathioninuria', 0.47126436781609193, 11.226325483970346, 2.3001232971519086, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(192286, 'HP:0003108', 'Hyperglycinuria', 'MP:0030616', 'hyperglycinuria', 0.6049382716049383, 16.607147267911277, 3.169589715489833, 'UPHENO:0068184', 'increased level of glycine in urine'),
(192287, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011890', 'increased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192288, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0008820', 'abnormal blood uric acid level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192289, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031079', 'increased circulating troponin I level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192290, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012616', 'increased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192291, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0002695', 'abnormal circulating glucagon level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192292, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031077', 'increased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192293, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0003349', 'abnormal circulating renin level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192294, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192295, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192296, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012333', 'increased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192297, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192298, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011892', 'abnormal circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192299, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011891', 'decreased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192300, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012221', 'abnormal circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192301, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0013256', 'increased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192302, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010215', 'abnormal circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192303, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192304, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0005567', 'decreased circulating total protein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192305, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010090', 'increased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192306, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192307, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0005308', 'abnormal circulating ammonia level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192308, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192309, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031075', 'abnormal circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192310, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031107', 'abnormal circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192311, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192312, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031083', 'increased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192313, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011885', 'abnormal circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192314, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012325', 'decreased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192315, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192316, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012327', 'abnormal circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192317, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0005416', 'abnormal circulating protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192318, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192319, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192320, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192321, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192322, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012622', 'increased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192323, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0013403', 'abnormal circulating lactate level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(192324, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020984', 'decreased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192325, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012621', 'decreased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192326, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0013255', 'abnormal circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192327, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192328, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192329, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192330, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192331, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031081', 'abnormal circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192332, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012619', 'increased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192333, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012614', 'abnormal circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192334, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012328', 'decreased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192335, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192336, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011912', 'abnormal circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192337, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012330', 'decreased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192338, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192339, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192340, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010091', 'decreased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192341, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011894', 'decreased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192342, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0004730', 'abnormal circulating gastrin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192343, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192344, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031082', 'decreased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192345, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031059', 'increased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192346, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031108', 'increased circulating myoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192347, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192348, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192349, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192350, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020246', 'abnormal circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192351, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192352, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020256', 'abnormal circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192353, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0005419', 'decreased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192354, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0001560', 'abnormal circulating insulin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192355, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192356, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192357, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192358, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192359, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192360, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192361, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012666', 'increased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192362, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192363, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192364, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192365, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010210', 'abnormal circulating cytokine level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192366, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192367, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192368, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011889', 'abnormal circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192369, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192370, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011886', 'increased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192371, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012618', 'decreased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192372, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012332', 'decreased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192373, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192374, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192375, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192376, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012222', 'decreased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192377, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031076', 'decreased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192378, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012329', 'increased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192379, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0008804', 'abnormal circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192380, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192381, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011887', 'decreased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192382, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011888', 'abnormal circulating total protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192383, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192384, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0002965', 'increased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192385, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192386, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192387, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0008806', 'increased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192388, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192389, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192390, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0002941', 'increased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192391, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020248', 'decreased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192392, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0030757', 'abnormal circulating histamine level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192393, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0001570', 'abnormal circulating enzyme level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192394, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012326', 'increased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192395, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192396, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192397, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192398, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020257', 'increased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192399, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020985', 'increased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192400, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192401, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192402, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192403, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020258', 'decreased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192404, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012324', 'abnormal circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192405, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192406, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192407, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192408, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012223', 'increased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192409, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012617', 'abnormal circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192410, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031065', 'increased circulating procalcitonin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192411, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192412, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011893', 'increased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192413, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0013257', 'decreased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192414, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020255', 'absent circulating factor XII protein', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192415, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0005667', 'abnormal circulating leptin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(192416, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012331', 'increased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192417, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192418, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020983', 'abnormal circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192419, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0012615', 'decreased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192420, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192421, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0008805', 'decreased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192422, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192423, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192424, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0031078', 'increased circulating troponin T level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192425, 'HP:0034619', 'Decreased circulating membrane cofactor protein concentration', 'MP:0020247', 'increased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(192426, 'HP:0031444', 'Dilatation of the tricuspid annulus', 'MP:0010628', 'patent tricuspid valve', 0.4423076923076923, 12.765845013930333, 2.3762220957791773, 'UPHENO:0076759', 'abnormal tricuspid valve morphology'),
(192427, 'HP:0031444', 'Dilatation of the tricuspid annulus', 'MP:0010627', 'enlarged tricuspid valve', 0.42592592592592593, 12.765845013930333, 2.3318028128006754, 'UPHENO:0076759', 'abnormal tricuspid valve morphology'),
(192428, 'HP:0031444', 'Dilatation of the tricuspid annulus', 'MP:0006132', 'calcified tricuspid valve', 0.4339622641509434, 12.765845013930333, 2.353698155253821, 'UPHENO:0076759', 'abnormal tricuspid valve morphology'),
(192429, 'HP:0031444', 'Dilatation of the tricuspid annulus', 'MP:0006123', 'tricuspid valve atresia', 0.4339622641509434, 12.765845013930333, 2.353698155253821, 'UPHENO:0076759', 'abnormal tricuspid valve morphology'),
(192430, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192431, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192432, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003996', 'clonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192433, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192434, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008672', 'increased interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192435, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001648', 'abnormal apoptosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192436, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030904', 'abnormal melanoblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192437, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000427', 'abnormal hair cycle', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192438, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006383', 'abnormal cochlear frequency tuning', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192439, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008699', 'increased interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192440, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192441, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001948', 'vesicoureteral reflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192442, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003476', 'decreased summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192443, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192444, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010520', 'sinoatrial block', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192445, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002136', 'abnormal kidney physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192446, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008567', 'decreased interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192447, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014029', 'increased respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192448, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010935', 'increased airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192449, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002421', 'abnormal cell-mediated immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192450, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012006', 'abnormal hippocampus physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192451, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004085', 'abnormal heartbeat', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192452, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192453, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192454, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003482', 'increased nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192455, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001914', 'hemorrhage', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192456, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001951', 'abnormal breathing pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192457, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009697', 'abnormal copulation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192458, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000327', 'hemosiderinuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192459, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031086', 'wheezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192460, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192461, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192462, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192463, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192464, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013136', 'genital discharge', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192465, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003431', 'abnormal parathyroid gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192466, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014030', 'abnormal mucous gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192467, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012011', 'febrile seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192468, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192469, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000064', 'failure of bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192470, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000738', 'impaired muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192471, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003412', 'abnormal afterhyperpolarization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192472, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030153', 'dental pulp inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192473, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192474, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014157', 'alacrima', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192475, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008558', 'abnormal interferon-beta secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192476, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192477, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009046', 'muscle twitch', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192478, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011043', 'abnormal lung elastance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192479, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005598', 'decreased ventricle muscle contractility', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192480, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002133', 'abnormal respiratory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192481, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008566', 'increased interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192482, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010334', 'pleural effusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192483, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010896', 'decreased lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192484, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011918', 'abnormal PQ interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192485, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010950', 'abnormal lung hysteresivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192486, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006273', 'abnormal urine organic cation level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192487, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004122', 'abnormal sinus arrhythmia', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192488, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021010', 'impaired synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192489, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192490, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009057', 'increased interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192491, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001664', 'abnormal digestion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192492, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003261', 'hematemesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192493, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031154', 'intestinal hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192494, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010506', 'prolonged RR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192495, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010394', 'decreased QRS amplitude', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192496, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011825', 'decreased cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192497, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001619', 'abnormal vascular permeability', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192498, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006046', 'atrioventricular valve regurgitation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192499, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192500, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192501, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010993', 'decreased surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192502, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192503, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001378', 'abnormal ejaculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192504, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001934', 'increased litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192505, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005600', 'increased ventricle muscle contractility', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192506, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000610', 'cholestasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192507, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010631', 'increased Q wave amplitude', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192508, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001756', 'abnormal urination', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192509, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003925', 'abnormal cellular glucose uptake', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192510, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005575', 'increased pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192511, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000951', 'sporadic seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192512, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192513, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004144', 'hypotonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192514, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003475', 'increased summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192515, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006002', 'abnormal small intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192516, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008003', 'achlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192517, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192518, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005551', 'abnormal eye electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192519, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004217', 'salt-sensitive hypertension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192520, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006111', 'abnormal coronary circulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192521, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192522, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004149', 'increased bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192523, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003039', 'increased time of peak ischemic contracture', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192524, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192525, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010141', 'lymphangitis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192526, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020142', 'increased anti-sperm antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192527, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012746', 'abnormal neural crest cell delamination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192528, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003547', 'abnormal pulmonary pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192529, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012033', 'abnormal ERG implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192530, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010393', 'shortened QRS complex duration', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192531, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192532, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192533, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003480', 'increased nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192534, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004046', 'abnormal mitosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192535, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001864', 'vascular inflammation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192536, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192537, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008814', 'decreased nerve conduction velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192538, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009384', 'cardiac valve regurgitation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192539, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003438', 'abnormal carotid body physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192540, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010954', 'abnormal cellular respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192541, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005000', 'abnormal immune tolerance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192542, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003820', 'increased left ventricle systolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192543, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030940', 'impaired autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192544, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002998', 'abnormal bone remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192545, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004877', 'abnormal systemic vascular resistance', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192546, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020154', 'impaired humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192547, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192548, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002161', 'abnormal fertility/fecundity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192549, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192550, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011951', 'increased cardiac stroke volume', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192551, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002007', 'increased cellular sensitivity to gamma-irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192552, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021053', 'abnormal renal arterial blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192553, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011220', 'increased intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192554, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006150', 'double vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192555, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010094', 'abnormal chromosome stability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192556, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020097', 'low mean heart rate adaptation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192557, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192558, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031170', 'abnormal vasculature physiology', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192559, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192560, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001633', 'poor circulation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192561, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020219', 'increased tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192562, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004156', 'abnormal QT variability', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192563, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006047', 'aortic valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192564, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011420', 'pyuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192565, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003394', 'increased cardiac output', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192566, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011994', 'increased nerve conduction velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192567, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003659', 'abnormal lymph circulation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192568, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192569, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008661', 'decreased interleukin-10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192570, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192571, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011952', 'decreased cardiac stroke volume', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192572, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004994', 'abnormal brain wave pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192573, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013638', 'decreased femur stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192574, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001917', 'intraventricular hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192575, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003880', 'abnormal central pattern generator function', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192576, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011953', 'prolonged PQ interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192577, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192578, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014275', 'increased respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192579, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003899', 'abnormal QT interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192580, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192581, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001599', 'abnormal blood volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192582, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003824', 'decreased left ventricle developed pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192583, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008697', 'decreased interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192584, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000351', 'increased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192585, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192586, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003009', 'abnormal cytokine secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192587, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030988', 'dysosmia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192588, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003122', 'maternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192589, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020002', 'increased response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192590, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008260', 'abnormal autophagy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192591, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012556', 'increased cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192592, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008002', 'hyperchlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192593, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008687', 'increased interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192594, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192595, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031424', 'enhanced female fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192596, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192597, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008678', 'increased interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192598, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192599, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192600, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013642', 'decreased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192601, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020371', 'abnormal glymphatic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192602, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013559', 'abnormal exocrine gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192603, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013556', 'abnormal holocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192604, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030975', 'placenta hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192605, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003725', 'increased autoantibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192606, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011421', 'cylindruria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192607, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192608, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013210', 'abnormal primary cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192609, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192610, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011936', 'abnormal PP interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192611, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002909', 'abnormal adrenal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192612, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009567', 'mitotic nondisjunction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192613, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192614, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003997', 'tonic-clonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192615, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003157', 'impaired muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192616, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192617, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003123', 'paternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192618, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011514', 'skin hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192619, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011048', 'decreased lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192620, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009247', 'meteorism', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192621, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004145', 'abnormal muscle electrophysiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192622, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192623, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004021', 'abnormal rod electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192624, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004245', 'genital hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192625, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192626, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192627, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003472', 'increased summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192628, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005044', 'sepsis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192629, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192630, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031013', 'abnormal egg activation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192631, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013171', 'ear hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192632, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004782', 'abnormal surfactant physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192633, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011047', 'increased lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192634, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031306', 'abnormal cartilage physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192635, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011702', 'abnormal fibroblast proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192636, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192637, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004743', 'abnormal vestibular evoked myogenic potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192638, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011928', 'abnormal mitral valve flow', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192639, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002952', 'ventricular cardiomyopathy', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192640, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003260', 'vomiting', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192641, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003252', 'abnormal bile duct physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192642, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004512', 'anosmia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192643, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031130', 'right-to-left shunt', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192644, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020220', 'decreased tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192645, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192646, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011824', 'increased cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192647, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192648, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192649, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031098', 'abnormal sputum production', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192650, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192651, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192652, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009643', 'abnormal urine homeostasis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192653, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192654, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031169', 'abnormal joint physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192655, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011809', 'abnormal anoikis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192656, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003469', 'decreased single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192657, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013145', 'eye discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192658, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008563', 'decreased interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192659, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031153', 'stomach hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192660, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002419', 'abnormal innate immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192661, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002896', 'abnormal bone mineralization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192662, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012111', 'failure of morula compaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192663, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008055', 'increased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192664, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004513', 'avnosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192665, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031425', 'enhanced male fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192666, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011925', 'abnormal heart echocardiography feature', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192667, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002472', 'impaired complement alternative pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192668, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013285', 'abnormal renal filtration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192669, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031483', 'decreased urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192670, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002128', 'abnormal blood circulation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192671, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004748', 'increased susceptibility to age-related hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192672, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006003', 'abnormal large intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192673, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011194', 'abnormal hair follicle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192674, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192675, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002999', 'abnormal bone healing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192676, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011518', 'abnormal cell chemotaxis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192677, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002987', 'abnormal urine osmolality', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192678, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010507', 'shortened RR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192679, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003762', 'abnormal immune organ physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192680, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003280', 'urinary incontinence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192681, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008722', 'abnormal chemokine secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192682, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005257', 'abnormal intraocular pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192683, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004759', 'decreased mitotic index', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192684, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002498', 'abnormal acute inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192685, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002420', 'abnormal adaptive immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192686, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002907', 'abnormal parturition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192687, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005025', 'abnormal response to infection', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192688, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011045', 'decreased lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192689, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192690, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192691, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008877', 'abnormal DNA methylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192692, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010936', 'decreased airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192693, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192694, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001533', 'abnormal skeleton physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192695, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004216', 'salt-resistant hypertension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192696, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002064', 'seizures', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192697, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021016', 'decreased tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192698, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192699, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005666', 'abnormal adipose tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192700, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005402', 'abnormal action potential', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192701, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192702, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011832', 'abnormal visual acuity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192703, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011046', 'abnormal lung tissue damping', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192704, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192705, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192706, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006112', 'angina', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192707, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008009', 'delayed cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192708, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014274', 'decreased respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192709, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005036', 'diarrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192710, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192711, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030575', 'decreased hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192712, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192713, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000233', 'abnormal blood flow velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192714, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192715, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004486', 'decreased response of heart to induced stress', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192716, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031105', 'rhonchi', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192717, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192718, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001876', 'decreased inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192719, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001761', 'abnormal urination pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192720, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192721, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192722, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192723, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003549', 'pulmonary hypotension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192724, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014037', 'stranguria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192725, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006266', 'decreased pulse pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192726, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006054', 'spinal hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192727, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192728, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006153', 'hypermetropia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192729, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010038', 'abnormal placenta physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192730, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192731, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004751', 'increased length of allograft survival', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192732, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004143', 'muscle hypertonia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192733, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014041', 'increased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192734, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013971', 'blood in lymph vessels', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192735, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020039', 'increased bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192736, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003470', 'abnormal summary potential', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192737, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192738, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008679', 'decreased interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192739, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000501', 'abnormal digestive secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192740, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192741, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008568', 'abnormal interleukin secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192742, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002338', 'abnormal pulmonary ventilation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192743, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012555', 'decreased cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192744, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192745, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004011', 'decreased diastolic filling velocity', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192746, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008705', 'increased interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192747, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004070', 'abnormal P wave', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192748, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011954', 'shortened PQ interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192749, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192750, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002409', 'decreased susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192751, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008651', 'increased interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192752, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010155', 'abnormal intestine physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192753, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192754, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008700', 'decreased interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192755, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012045', 'increased susceptibility to hypertension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192756, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001844', 'autoimmune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192757, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009275', 'bruising', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192758, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008709', 'decreased interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192759, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192760, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004120', 'cardiac ischemia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192761, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020974', 'abnormal FO-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192762, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001665', 'chronic diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192763, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009668', 'ectopic pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192764, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004736', 'abnormal distortion product otoacoustic emission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192765, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010516', 'absent Q wave', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192766, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031152', 'subcutaneous hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192767, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031128', 'cardiovascular shunt', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192768, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006043', 'decreased apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192769, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031402', 'decreased muscle fatigability', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192770, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011938', 'prolonged PP interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192771, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000947', 'convulsive seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192772, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001542', 'abnormal bone strength', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192773, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008685', 'decreased interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192774, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192775, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000231', 'hypertension', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192776, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192777, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012035', 'abnormal b-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192778, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192779, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031155', 'small intestine hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192780, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004211', 'abnormal sour taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192781, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192782, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001954', 'respiratory distress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192783, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011466', 'increased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192784, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011044', 'increased lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192785, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192786, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012745', 'abnormal neural crest cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192787, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010559', 'heart block', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192788, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001634', 'internal hemorrhage', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192789, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192790, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011082', 'abnormal gastrointestinal motility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192791, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013468', 'chromodacryorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192792, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004878', 'increased systemic vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192793, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008555', 'abnormal interferon secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192794, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012565', 'perivasculitis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192795, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020414', 'abnormal fibroblast physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192796, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010553', 'prolonged HV interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192797, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002296', 'aspiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192798, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001986', 'abnormal taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192799, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020218', 'abnormal tear production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192800, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005167', 'abnormal blood-brain barrier function', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192801, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003091', 'abnormal cell migration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192802, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002334', 'abnormal airway responsiveness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192803, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001800', 'abnormal humoral immune response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192804, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030214', 'muscle fasciculation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192805, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192806, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004587', 'decreased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192807, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008706', 'decreased interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192808, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000350', 'abnormal cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192809, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001837', 'defective assembly of class I molecules', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192810, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010515', 'abnormal Q wave', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192811, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000423', 'delayed hair regrowth', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192812, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192813, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005501', 'abnormal skin physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192814, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010636', 'bundle branch block', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192815, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002328', 'abnormal airway resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192816, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031124', 'aortic valve inflammation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192817, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192818, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003474', 'abnormal summary potential intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192819, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192820, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004812', 'abnormal linear vestibular evoked potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192821, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003116', 'rickets', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192822, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192823, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003216', 'absence seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192824, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192825, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006049', 'semilunar valve regurgitation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192826, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031423', 'abnormal luteolysis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192827, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008272', 'abnormal endochondral bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192828, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014028', 'decreased respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192829, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010994', 'aerophagia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192830, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010822', 'pneumothorax', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192831, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003466', 'decreased single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192832, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008663', 'increased interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192833, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008681', 'increased interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192834, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020848', 'abnormal exocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192835, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005001', 'abnormal clonal deletion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192836, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192837, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001943', 'abnormal respiration', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192838, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192839, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192840, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002826', 'tonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192841, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192842, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008817', 'hematoma', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192843, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011399', 'increased endoneurial fluid pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192844, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192845, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009473', 'abnormal skin exfoliation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192846, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005333', 'decreased heart rate', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192847, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020846', 'abnormal cell motility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192848, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192849, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006335', 'abnormal hearing electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192850, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002893', 'ketoaciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192851, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002471', 'abnormal complement pathway', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192852, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192853, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031109', 'subarachnoid hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192854, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009276', 'ecchymosis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192855, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001663', 'abnormal digestive system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192856, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031302', 'syncope', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192857, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031051', 'lymph node hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192858, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192859, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008688', 'decreased interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192860, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030924', 'early exit from telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192861, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192862, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010028', 'aciduria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192863, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003865', 'lymph node inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192864, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192865, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020000', 'abnormal response to antigen', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192866, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030216', 'tongue muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192867, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192868, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001856', 'myocarditis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192869, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001629', 'abnormal heart rate', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192870, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003011', 'delayed dark adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192871, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005621', 'abnormal cell physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192872, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031126', 'gangrene', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192873, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192874, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008747', 'abnormal T cell anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192875, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001835', 'abnormal antigen presentation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192876, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192877, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192878, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014182', 'decreased respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192879, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008403', 'decreased cellular sensitivity to alkylating agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192880, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014132', 'abnormal tear film physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192881, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004022', 'abnormal cone electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192882, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030132', 'periodontium inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192883, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012200', 'increased endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192884, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192885, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192886, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004213', 'abnormal umami taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192887, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192888, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001752', 'abnormal hypothalamus secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192889, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004781', 'abnormal surfactant composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192890, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004879', 'decreased systemic vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192891, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020147', 'abnormal defecation amount', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192892, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010634', 'increased QRS amplitude', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192893, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002988', 'decreased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192894, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192895, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192896, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003889', 'enhanced sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192897, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003259', 'nausea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192898, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004773', 'abnormal bile composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192899, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012553', 'decreased serum complement activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192900, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010505', 'abnormal T wave', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192901, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002164', 'abnormal gland physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192902, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192903, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192904, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192905, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003193', 'decreased cholesterol efflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192906, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030951', 'abnormal endocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192907, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005004', 'abnormal lymphocyte anergy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192908, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008004', 'abnormal stomach pH', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192909, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003256', 'biliary cirrhosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192910, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001596', 'hypotension', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192911, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004086', 'absent heartbeat', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192912, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009645', 'crystalluria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192913, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006045', 'mitral valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192914, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192915, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192916, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002327', 'abnormal respiratory function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192917, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020001', 'decreased response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192918, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011923', 'abnormal bladder urine volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192919, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008008', 'early cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192920, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020080', 'increased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192921, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031129', 'left-to-right shunt', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192922, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000920', 'abnormal myelination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192923, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001927', 'abnormal estrous cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192924, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011397', 'endoneurial edema', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192925, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002635', 'reduced sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192926, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003293', 'rectal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192927, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002879', 'increased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192928, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013752', 'stridor', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192929, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011900', 'podocyturia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192930, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003741', 'tinnitus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192931, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013632', 'increased femur maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192932, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001963', 'abnormal hearing physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192933, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005671', 'abnormal response to transplant', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192934, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192935, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013557', 'abnormal merocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192936, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002406', 'increased susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192937, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000503', 'excessive digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192938, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011931', 'abnormal pulmonary valve flow', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192939, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009062', 'impaired lectin complement pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192940, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192941, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002333', 'abnormal lung compliance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192942, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000313', 'abnormal cell death', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192943, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192944, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009358', 'environmentally induced seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192945, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008702', 'increased interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192946, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010992', 'increased surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192947, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008001', 'hypochlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192948, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003566', 'abnormal cell adhesion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192949, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005647', 'abnormal sex gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192950, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020096', 'high mean heart rate adaptation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192951, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011432', 'decreased urine flow rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192952, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031009', 'abnormal sperm-egg fusion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192953, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000743', 'muscle spasm', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192954, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031117', 'subdural hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192955, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192956, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012201', 'decreased endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192957, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004072', 'abnormal frontal plane axis', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192958, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004742', 'abnormal vestibular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192959, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009661', 'abnormal pregnancy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192960, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031091', 'hypogeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192961, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012554', 'increased serum complement activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192962, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005595', 'abnormal vascular smooth muscle physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192963, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005532', 'abnormal vascular resistance', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192964, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003882', 'abnormal pulse pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192965, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192966, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008660', 'increased interleukin-10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192967, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001912', 'increased cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192968, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012032', 'abnormal ERG latency', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192969, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003875', 'abnormal hair follicle regression', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192970, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004003', 'abnormal vascular endothelial cell physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192971, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012124', 'increased bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192972, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008942', 'abnormal induced cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192973, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003900', 'shortened QT interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192974, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192975, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001924', 'infertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192976, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009698', 'heart hemorrhage', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192977, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001853', 'heart inflammation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192978, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008682', 'decreased interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192979, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001915', 'intracranial hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192980, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192981, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192982, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008402', 'increased cellular sensitivity to alkylating agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192983, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008712', 'decreased interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192984, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192985, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010377', 'abnormal gut flora balance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192986, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002842', 'increased systemic arterial blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192987, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005085', 'abnormal gallbladder physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192988, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192989, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008652', 'decreased interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192990, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031479', 'increased urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192991, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(192992, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003186', 'abnormal redox activity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192993, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001666', 'abnormal intestinal absorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192994, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192995, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031480', 'abnormal urine xanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192996, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192997, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001379', 'abnormal penile erection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192998, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001947', 'abnormal mucociliary clearance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(192999, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001636', 'irregular heartbeat', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193000, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013634', 'increased femur fracture load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193001, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193002, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031136', 'muscle hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193003, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009732', 'ventricular premature beat', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193004, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008676', 'decreased interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193005, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193006, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002293', 'long gestation period', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193007, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193008, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001727', 'abnormal embryo implantation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193009, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193010, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193011, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010957', 'abnormal aerobic respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193012, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005245', 'hemarthrosis', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193013, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193014, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013637', 'increased femur stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193015, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012034', 'abnormal a-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193016, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006048', 'pulmonary valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193017, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193018, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193019, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193020, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002322', 'abnormal respiratory transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193021, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000249', 'abnormal blood vessel physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193022, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003473', 'decreased summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193023, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010895', 'increased lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193024, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193025, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010512', 'absent PR interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193026, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193027, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002693', 'abnormal pancreas physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193028, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031385', 'enhanced blood-brain barrier function', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193029, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031014', 'polyspermy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193030, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193031, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010552', 'abnormal HV interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193032, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008775', 'abnormal heart ventricle pressure', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193033, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193034, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193035, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193036, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021015', 'increased tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193037, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008407', 'decreased cellular sensitivity to hydrogen peroxide', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193038, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006052', 'cerebellum hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193039, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006138', 'congestive heart failure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193040, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011717', 'increased interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193041, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193042, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021009', 'abnormal synaptic physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193043, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012120', 'trophectoderm cell degeneration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193044, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006265', 'increased pulse pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193045, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003077', 'abnormal cell cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193046, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003635', 'abnormal synaptic transmission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193047, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003464', 'abnormal single cell response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193048, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002634', 'abnormal sensorimotor gating', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193049, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008696', 'increased interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193050, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014201', 'abnormal intestinal epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193051, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001845', 'abnormal inflammatory response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193052, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004010', 'increased diastolic filling velocity', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193053, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009349', 'increased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193054, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005435', 'hemoperitoneum', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193055, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031481', 'decreased urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193056, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010381', 'abnormal dosage compensation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193057, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005005', 'abnormal self tolerance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193058, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193059, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004012', 'increased pulmonary artery pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193060, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193061, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010741', 'abnormal melanocyte proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193062, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010504', 'abnormal RR interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193063, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010756', 'decreased right ventricle peak pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193064, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004597', 'increased susceptibility to noise-induced hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193065, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009058', 'decreased interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193066, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193067, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193068, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003468', 'increased single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193069, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013627', 'increased vertebra yield load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193070, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010072', 'increased pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193071, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003787', 'abnormal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193072, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004036', 'abnormal muscle relaxation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193073, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008544', 'impaired olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193074, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020418', 'increased cardiac muscle relaxation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193075, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002294', 'short gestation period', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193076, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011221', 'decreased intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193077, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193078, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008006', 'increased stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193079, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030941', 'enhanced autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193080, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001790', 'abnormal immune system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193081, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193082, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008744', 'abnormal B cell anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193083, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008562', 'increased interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193084, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003901', 'abnormal PR interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193085, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001857', 'pericarditis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193086, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193087, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011929', 'abnormal aortic valve flow', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193088, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031221', 'abnormal CXCL10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193089, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031192', 'coronary artery spasm', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193090, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003896', 'prolonged PR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193091, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031118', 'cardiovalvulitis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193092, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008271', 'abnormal bone ossification', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193093, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193094, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193095, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002330', 'abnormal bronchial provocation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193096, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006110', 'ventricular fibrillation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193097, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011758', 'renal ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193098, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031092', 'dysgeusia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193099, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030938', 'abnormal reticulophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193100, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003089', 'decreased skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193101, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008669', 'increased interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193102, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010560', 'intraventricular block', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193103, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003192', 'increased cholesterol efflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193104, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011930', 'abnormal tricuspid valve flow', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193105, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003467', 'abnormal single cell response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193106, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193107, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005253', 'abnormal eye physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193108, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005530', 'decreased renal vascular resistance', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193109, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003823', 'increased left ventricle developed pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193110, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003866', 'abnormal defecation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193111, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003037', 'increased myocardial infarct size', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193112, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008007', 'abnormal cellular replicative senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193113, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013641', 'increased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193114, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004558', 'delayed allantois development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193115, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008664', 'decreased interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193116, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020138', 'delayed bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193117, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003898', 'abnormal QRS complex', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193118, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008708', 'increased interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193119, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011718', 'decreased interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193120, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006203', 'eye hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193121, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193122, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000751', 'myopathy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193123, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193124, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193125, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193126, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193127, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003034', 'increased pulmonary vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193128, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193129, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193130, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003927', 'increased cellular glucose import', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193131, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008565', 'decreased interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193132, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010514', 'fragmented QRS complex', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193133, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012125', 'decreased bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193134, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008684', 'increased interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193135, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010071', 'abnormal pruritus', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193136, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003926', 'decreased cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193137, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001598', 'abnormal blood viscosity', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193138, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006042', 'increased apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193139, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002876', 'abnormal thyroid gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193140, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014043', 'decreased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193141, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031090', 'ageusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193142, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005403', 'abnormal nerve conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193143, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031469', 'abnormal pinocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193144, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013135', 'poor circulation in tail', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193145, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008005', 'decreased stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193146, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003292', 'melena', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193147, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193148, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030215', 'facial muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193149, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193150, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010752', 'impaired mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193151, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010073', 'decreased pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193152, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009344', 'abnormal ovulation cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193153, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011927', 'abnormal cardiac valve flow', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193154, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193155, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193156, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004484', 'abnormal response of heart to induced stress', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193157, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031102', 'rhinorrhea', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193158, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004859', 'abnormal synaptic plasticity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193159, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003471', 'abnormal summary potential threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193160, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006152', 'tunnel vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193161, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003928', 'increased heart rate variability', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193162, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193163, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193164, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193165, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013555', 'abnormal apocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193166, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005076', 'abnormal cell differentiation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193167, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008564', 'increased interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193168, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005531', 'increased renal vascular resistance', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193169, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193170, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031223', 'increased CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193171, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030619', 'homogentisic aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193172, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002090', 'abnormal vision', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193173, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013208', 'abnormal cilium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193174, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013636', 'abnormal bone stiffness', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193175, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193176, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010513', 'abnormal ventricular activation time', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193177, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193178, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001919', 'abnormal reproductive system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193179, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010571', 'shortened ST segment', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193180, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193181, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004244', 'abnormal miscarriage rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193182, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193183, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031127', 'dry gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193184, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008943', 'increased sensitivity to induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193185, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001627', 'abnormal cardiac output', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193186, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012685', 'abnormal primitive streak elongation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193187, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004071', 'prolonged P wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193188, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193189, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001854', 'atrial endocarditis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193190, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193191, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193192, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003621', 'dysuria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193193, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193194, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005088', 'increased acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193195, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020439', 'absent b-wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193196, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193197, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001337', 'dry eyes', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193198, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193199, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002578', 'impaired ability to fire action potentials', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193200, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010511', 'shortened PR interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193201, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004738', 'abnormal auditory brainstem response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193202, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006001', 'abnormal intestinal transit time', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193203, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020845', 'abnormal DNA-templated transcription', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193204, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013644', 'increased vertebra maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193205, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009348', 'abnormal urine pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193206, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020412', 'abnormal amnion physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193207, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005599', 'increased cardiac muscle contractility', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193208, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031066', 'cytokine storm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193209, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000740', 'impaired smooth muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193210, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003233', 'prolonged QT interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193211, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001921', 'reduced fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193212, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010509', 'decreased P wave amplitude', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193213, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030909', 'abnormal melanocyte adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193214, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004760', 'increased mitotic index', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193215, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009350', 'decreased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193216, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011805', 'decreased cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193217, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006332', 'abnormal cochlear potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193218, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001953', 'respiratory failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193219, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193220, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193221, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193222, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013561', 'abnormal endocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193223, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193224, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193225, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013806', 'encephalopathy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193226, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000316', 'cellular necrosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193227, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003548', 'pulmonary hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193228, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008691', 'decreased interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193229, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014183', 'increased respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193230, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003483', 'decreased nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193231, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193232, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193233, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001819', 'abnormal immune cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193234, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003038', 'decreased myocardial infarct size', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193235, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005620', 'abnormal muscle contractility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193236, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030933', 'hyphema', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193237, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008145', 'hemeralopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193238, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012305', 'umbilical cord hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193239, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031089', 'sneezing', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193240, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010392', 'prolonged QRS complex duration', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193241, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004925', 'decreased susceptibility to noise-induced hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193242, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013639', 'decreased bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193243, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193244, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004039', 'abnormal cardiac cell glucose uptake', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193245, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001983', 'abnormal olfactory system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193246, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002694', 'abnormal pancreas secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193247, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011926', 'abnormal heart valve physiology', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193248, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004766', 'decreased susceptibility to age-related hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193249, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193250, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031222', 'decreased CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193251, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008711', 'increased interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193252, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011417', 'abnormal renal transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193253, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004037', 'increased muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193254, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013134', 'poor circulation in autopods', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193255, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014046', 'abnormal mitophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193256, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012197', 'impaired myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193257, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193258, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001952', 'increased airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193259, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008069', 'abnormal joint mobility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193260, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000948', 'nonconvulsive seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193261, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006080', 'brain ischemia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193262, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010570', 'prolonged ST segment', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193263, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193264, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002500', 'granulomatous inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193265, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004780', 'abnormal surfactant secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193266, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003897', 'abnormal ST segment', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193267, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193268, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009562', 'abnormal odor adaptation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193269, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031156', 'large intestine hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193270, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006051', 'brainstem hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193271, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003589', 'abnormal ureter physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193272, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001613', 'abnormal vasodilation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193273, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020040', 'decreased bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193274, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003699', 'abnormal female reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193275, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010753', 'improved mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193276, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008406', 'increased cellular sensitivity to hydrogen peroxide', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193277, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002292', 'abnormal gestational length', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193278, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004485', 'increased response of heart to induced stress', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193279, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005529', 'abnormal renal vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193280, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193281, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005275', 'abnormal skin tensile strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193282, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001984', 'abnormal olfaction', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193283, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002335', 'decreased airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193284, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003375', 'abnormal menstrual cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193285, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008776', 'increased right ventricle peak pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193286, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003674', 'oxidative stress', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193287, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008748', 'abnormal central T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193288, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193289, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005330', 'cardiomyopathy', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193290, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010554', 'shortened HV interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193291, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193292, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003477', 'abnormal nerve fiber response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193293, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001846', 'increased inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193294, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002106', 'abnormal muscle physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193295, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003207', 'decreased cellular sensitivity to gamma-irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193296, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193297, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004014', 'abnormal uterine environment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193298, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003298', 'choking', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193299, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011920', 'abnormal S wave', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193300, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193301, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013305', 'isosthenuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193302, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006044', 'tricuspid valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193303, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020155', 'enhanced humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193304, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193305, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010386', 'abnormal urinary bladder physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193306, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001916', 'intracerebral hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193307, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193308, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011937', 'shortened PP interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193309, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005087', 'decreased acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193310, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193311, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193312, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193313, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005576', 'decreased pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193314, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030129', 'tongue inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193315, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010107', 'abnormal renal reabsorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193316, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008995', 'early reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193317, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000343', 'abnormal response to cardiac infarction', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193318, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002796', 'impaired skin barrier function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193319, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006388', 'abnormal auditory summating potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193320, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004142', 'abnormal muscle tone', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193321, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010143', 'enhanced fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193322, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031471', 'abnormal micropinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193323, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006053', 'hypothalamus hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193324, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031104', 'crackles', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193325, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012382', 'abnormal blood cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193326, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010519', 'atrioventricular block', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193327, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011431', 'increased urine flow rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193328, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003929', 'decreased heart rate variability', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193329, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031088', 'coughing', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193330, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012697', 'abnormal maternal body weight gain', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193331, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008861', 'abnormal hair shedding', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193332, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013625', 'increased femur yield load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193333, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020381', 'muscle gating pore current', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193334, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031484', 'increased urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193335, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014120', 'focal seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193336, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010758', 'increased right ventricle systolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193337, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002499', 'chronic inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193338, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011467', 'decreased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193339, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193340, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193341, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003633', 'abnormal nervous system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193342, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003878', 'abnormal ear physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193343, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000465', 'gastrointestinal hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193344, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012040', 'abnormal c-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193345, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003096', 'increased corneal light-scattering', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193346, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013127', 'epistaxis', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193347, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008670', 'decreased interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193348, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003393', 'decreased cardiac output', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193349, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006109', 'fibrillation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193350, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001935', 'decreased litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193351, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008703', 'decreased interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193352, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010946', 'hyperpnea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193353, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004752', 'decreased length of allograft survival', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193354, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001950', 'abnormal respiratory sounds', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193355, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001793', 'abnormal susceptibility to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193356, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011418', 'leukocyturia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193357, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003465', 'increased single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193358, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003463', 'abnormal single cell response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193359, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006336', 'abnormal otoacoustic response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193360, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003698', 'abnormal male reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193361, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020137', 'decreased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193362, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193363, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002314', 'abnormal respiratory mechanics', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193364, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008673', 'decreased interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193365, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002841', 'impaired skeletal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193366, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008690', 'increased interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193367, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010637', 'sinus bradycardia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193368, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193369, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0031470', 'abnormal macropinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193370, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003481', 'decreased nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193371, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005140', 'decreased cardiac muscle contractility', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193372, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005037', 'mucous diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193373, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193374, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008675', 'increased interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193375, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001933', 'abnormal litter size', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193376, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002626', 'increased heart rate', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193377, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010748', 'abnormal visual evoked potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193378, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193379, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193380, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004212', 'abnormal salty taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193381, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193382, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0014031', 'abnormal submucosal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193383, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193384, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008543', 'atrial fibrillation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193385, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005043', 'defective assembly of class II molecules', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193386, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193387, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193388, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0012046', 'decreased susceptibility to hypertension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193389, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0009045', 'muscle tetany', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193390, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002295', 'abnormal pulmonary circulation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193391, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010695', 'abnormal blood pressure regulation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193392, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003726', 'decreased autoantibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193393, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0002723', 'abnormal immune serum protein physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193394, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004013', 'decreased pulmonary artery pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193395, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013475', 'delayed reproductive senescence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193396, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000533', 'kidney hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193397, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030574', 'increased hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193398, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006114', 'cardiac murmur', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193399, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011804', 'increased cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193400, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000505', 'decreased digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193401, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0013640', 'increased bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193402, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020345', 'abnormal myocardial fiber currents', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193403, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0030939', 'abnormal autophagosome formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193404, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001945', 'bronchoconstriction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193405, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0005410', 'abnormal fertilization', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193406, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193407, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0006190', 'retina ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193408, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0000352', 'decreased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193409, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003868', 'abnormal feces composition', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193410, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011444', 'abnormal renal water homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193411, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003100', 'myopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193412, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0003777', 'lip inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193413, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193414, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008950', 'ventricular tachycardia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193415, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0001985', 'abnormal gustatory system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193416, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193417, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004945', 'abnormal bone resorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193418, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0011919', 'abnormal R wave', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193419, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0010510', 'absent P wave', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(193420, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193421, 'HP:0030872', 'Abnormal cardiac ventricular function', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193422, 'HP:0025679', 'Diskitis', 'MP:0006322', 'abnormal perichondrium morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(193423, 'HP:0025679', 'Diskitis', 'MP:0004704', 'short vertebral column', 0.40476190476190477, 8.052558416233639, 1.8053722283122766, 'UPHENO:0002813', 'abnormal vertebral column'),
(193424, 'HP:0025679', 'Diskitis', 'MP:0004610', 'small vertebrae', 0.4146341463414634, 8.052558416233639, 1.8272563270597264, 'UPHENO:0002813', 'abnormal vertebral column'),
(193425, 'HP:0025679', 'Diskitis', 'MP:0008771', 'elongated vertebral column', 0.40476190476190477, 8.052558416233639, 1.8053722283122766, 'UPHENO:0002813', 'abnormal vertebral column'),
(193426, 'HP:0025679', 'Diskitis', 'MP:0004703', 'abnormal vertebral column morphology', 0.4117647058823529, 8.052558416233639, 1.8209226638879836, 'UPHENO:0002813', 'abnormal vertebral column'),
(193427, 'HP:0025679', 'Diskitis', 'MP:0002114', 'abnormal axial skeleton morphology', 0.40625, 6.976576768886775, 1.6835184324385202, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(193428, 'HP:0025679', 'Diskitis', 'MP:0013844', 'abnormal perichondrial ossification', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(193429, 'HP:0025679', 'Diskitis', 'MP:0021136', 'abnormal vertebrae shape', 0.40476190476190477, 8.052558416233639, 1.8053722283122766, 'UPHENO:0002813', 'abnormal vertebral column'),
(193430, 'HP:0025679', 'Diskitis', 'MP:0003200', 'calcified joint', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(193431, 'HP:0007021', 'Pain insensitivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193432, 'HP:0007021', 'Pain insensitivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193433, 'HP:0007021', 'Pain insensitivity', 'MP:0014120', 'focal seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193434, 'HP:0007021', 'Pain insensitivity', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193435, 'HP:0007021', 'Pain insensitivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193436, 'HP:0007021', 'Pain insensitivity', 'MP:0008921', 'increased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193437, 'HP:0007021', 'Pain insensitivity', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193438, 'HP:0007021', 'Pain insensitivity', 'MP:0004835', 'abnormal miniature endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193439, 'HP:0007021', 'Pain insensitivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193440, 'HP:0007021', 'Pain insensitivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193441, 'HP:0007021', 'Pain insensitivity', 'MP:0004513', 'avnosmia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193442, 'HP:0007021', 'Pain insensitivity', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193443, 'HP:0007021', 'Pain insensitivity', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193444, 'HP:0007021', 'Pain insensitivity', 'MP:0002916', 'increased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193445, 'HP:0007021', 'Pain insensitivity', 'MP:0011397', 'endoneurial edema', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193446, 'HP:0007021', 'Pain insensitivity', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193447, 'HP:0007021', 'Pain insensitivity', 'MP:0003997', 'tonic-clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193448, 'HP:0007021', 'Pain insensitivity', 'MP:0002826', 'tonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193449, 'HP:0007021', 'Pain insensitivity', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193450, 'HP:0007021', 'Pain insensitivity', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193451, 'HP:0007021', 'Pain insensitivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193452, 'HP:0007021', 'Pain insensitivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193453, 'HP:0007021', 'Pain insensitivity', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193454, 'HP:0007021', 'Pain insensitivity', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193455, 'HP:0007021', 'Pain insensitivity', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193456, 'HP:0007021', 'Pain insensitivity', 'MP:0011994', 'increased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193457, 'HP:0007021', 'Pain insensitivity', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193458, 'HP:0007021', 'Pain insensitivity', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193459, 'HP:0007021', 'Pain insensitivity', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193460, 'HP:0007021', 'Pain insensitivity', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193461, 'HP:0007021', 'Pain insensitivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(193462, 'HP:0007021', 'Pain insensitivity', 'MP:0003996', 'clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(193463, 'HP:0007021', 'Pain insensitivity', 'MP:0003473', 'decreased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
